BakinLab

Our team of graduate and undergraduate students investigates genetics and genomics of cancer progression and metastasis.

[BakinLab @BakinLab]

@RachaelKohrn Thank you Rachael!

[BakinLab @BakinLab]

Congratulations to all our team members. Our new paper was just published at Cell Reports Medicine: A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers: Cell Reports Medicine

[BakinLab @BakinLab]

https://t.co/rcwLmK4Wv0

[BakinLab @BakinLab]

A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorec… https://t.co/LfL8RCmzKa

[BakinLab @BakinLab]

soon upcoming our new paper in Cell Reports Medicine on a novel two-drug therapy targeting p53-deficient colorectal and pancreatic cancers.

[Department of Cancer Genetics and Genomics @GeneticsRoswell]

Love to see great basic science moving into the clinic. Congrats to Dr. Christos Fountzilas @RoswellPark on his @NCCN YI award on novel combination therapy for colorectal/esophagogastric cancers. This work builds on @GeneticsRoswell expert Dr.Andrei Bakin’s work on p53 and BER.

[BakinLab @BakinLab]

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair https://t.co/6grQNhKVMw

[BakinLab @BakinLab]

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair https://t.co/pENSt1eWAy a new study from @BakinLab

[BakinLab @BakinLab]

@CommsBio just published a paper exploring a new therapeutic approach targeting p53 mutant cancer using a combination of fluorinated deoxyuridines and PARP1 inhibitors https://t.co/dTqeJ8kfme.

[BakinLab @BakinLab]

Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis https://t.co/0r9gerj8Gs

[BakinLab @BakinLab]

See more details on this paper https://t.co/Bx6SCqI9U2

[BakinLab @BakinLab]

@GeneticsRoswell Please see https://t.co/Bx6SCqI9U2

[Department of Cancer Genetics and Genomics @GeneticsRoswell]

A new strategy targeting p53 mutant cancer is presented by BakinLab https://t.co/6bDRG18DwJ Congratulations to the Team!